Randy st. Laurent

Randy St. Laurent has extensive experience in sales and operations in the pharmaceutical industry. Randy has held various leadership positions, including Vice President of Sales at Portola Pharmaceuticals, where they oversaw the successful launch of Andexxa. At Theravance Biopharma, they built a sales team and increased sales quarter over quarter for Vibativ. As VP of Sales at Cadence, they achieved high formulary approval rate and sales for Ofirmev. At ARCA biopharma, they led sales and marketing efforts for Bucindolol. At Scios, they played a key role in the launch of Natrecor and managed a large sales and operations budget. Additionally, at Transkaryotic Therapies, they built a sales team for the commercial launch of Replagal. Randy began their career at Genentech USA, where they achieved rapid promotions and launched successful oncology products.

Randy St. Laurent has a Bachelor's Degree in Marketing from The Ohio State University. No specific start or end year for this education is provided.